Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net (loss)/income	$ (4,479)	$ (14,679)	$ 10,551
Adjustments to reconcile net (loss)/income to net cash provided by operating activities:
Depreciation and amortization	10,253	8,061	6,597
Equity-based compensation	18,224	29,457	7,185
Non-cash interest expense; amortization of debt costs	207	921	639
Loss on debt modification	0	932	682
Deferred income taxes	1,342	1,134	208
(Gain)/loss on disposal of long-lived assets	(212)	147	0
Changes in assets and liabilities
Taxes receivable	890	(2,831)	0
Prepaid expense and other current assets	466	(5)	(3,845)
Other assets	(3,814)	(7,274)	(1,305)
Accounts payable	(206)	865	1,576
Deferred revenue and patient deposits	(896)	(452)	(423)
Accrued and other liabilities	2,181	8,171	4,768
Net cash provided by operating activities	23,956	24,447	26,633
Cash flows from investing activities
Purchases of property and equipment, net	(9,919)	(12,921)	(7,116)
Net cash used in investing activities	(9,919)	(12,921)	(7,116)
Cash flows from financing activities
Payment on term loan	(12,125)	(84,263)	(838)
Borrowings on term loan, net	0	83,503	49,603
Proceeds from IPO	0	0	13,542
Distribution to member	(79)	(1,159)	(66,856)
Dividends paid to shareholders	(385)	(23,160)	0
Payment of taxes withheld through vested equity-based compensation	(233)	(2,031)	0
Other financing activity	(569)	(147)	0
Net cash used in financing activities	(13,391)	(27,257)	(4,549)
Net decrease in cash and cash equivalents	646	(15,731)	14,968
Cash and cash equivalents
Beginning of period	9,616	25,347	10,379
End of period	10,262	9,616	25,347
Supplemental disclosure of cash flow information:
Cash paid for interest	6,277	5,830	4,255
Cash paid for taxes	4,663	4,932	0
Supplemental disclosure of non-cash investing information:
Property and equipment included in accounts payable and accrued expenses	283	1,113	255
Distributions to member included in accrued expenses	$ 0	$ 0	$ 427